Growth through Acquisition NIRx was acquired by Gilde Healthcare in 2025, signaling validated market potential and readiness for scale. This presents a strategic entry point for co-selling with Gilde-backed entities and leveraging new funding to expand product adoption in research institutions.

Product Expansion Recent launches including Satori 2.0 and NIRxWINGS2 indicate an ongoing push into advanced software and multimodal sensing capabilities. This creates opportunities to upsell higher-tier analysis tools, Python integration, and enhanced data visualization to existing customers.

Strategic Partnerships Industry collaborations such as the 2025 Artinis partnership underscore a move toward ecosystem partnerships. There is potential to frame joint offerings with compatible hardware/software providers to deliver end-to-end fNIRS research solutions to labs.

Global Reach With offices in Orlando and Berlin and a differentiated EU presence, there is headroom to pursue region-specific sales motions, localized support, and training programs, expanding customer acquisition across North America and Europe.

Knowledge Leadership Strong emphasis on training via the NIRx Learning Center and continuous education through online guides supports customer onboarding and retention. This can be leveraged to offer premium training bundles, certification programs, and value-based service contracts to research institutions.